Clinical course of percutaneous cholecystostomies: A cross-sectional study

Table 1 Clinicopathological features of the patients

Patient	Feature
Age-median (minimum-maximum)	76 (35-98)
Sex-Male/Female	45 (54.9%)/37 (45.1%)
CRP/WBCC, mean ± SD	152.48 ± 116.11 mg/L/15.306 ± 7.970 μL
Acute Cholecystitis Grades1
Grade I	25 (30.5%)
Grade II	34 (41.5%)
Grade III	23 (28%)
ASA Score
≥ III	78 (95.1%)
< III	4 (4.9%)
Operation type
Open cholecystectomy	8 (9.75%)
Laparoscopic cholecystectomy	1 (1.2%)
No operation	73 (89.1%)
Catheter removal time (d)-median (minimum-maximum)	7 (4-13)
Mortality at hospital after PC, n (%)	16 (19.5%)
Acute Cholecystitis attack after PC, n (%)	2 (3%)
After PC
Follow-up time (wk)- median (minimum-maximum)	128 (12-365)
Lifetime (wk) - median (minimum-maximum)	36 (1-332)

¹According to Tokyo Guidelines 2018. CRP: C-reactive protein; WBCC: White blood cell count; SD: Standard deviation; PC: Percutaneous cholecystostomy; CCI: Charlson comorbidity index; ASA: American Society of Anesthesiologists’ physical status score; IQR: Inter quarter range.

Table 2 Comparison of the patients that died in hospital and those that were discharged

			Died in hospital, n (%)	Discharged, n (%)	P value
CCI	≥ 2		9 (26.4%)	25 (73.5%)	0.2583
	< 2		7 (14.5%)	41 (85.4%)
ASA	≥ III		16 (100%)	0 (0%)	0.0001
	< III		0 (0%)	66 (100%)
WBCC	Median (IQR)		14400 (10000-19800)	10500 (7900-15300)	0.025
Age	Median (minimum-maximum)		76 (67-82)	80 (65-85.5)	0.695

CCI: Charlson; CCCI: Charlson comorbidity index; ASA: American society of Anesthesiologists’ physical status score; WBCC: White blood cell count; IQR: Inter quartile range.